Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06627205 · ClinicalTrials.gov registry record · NA

Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism

A NA study of Autism and Autism Spectrum Disorder (ASD), sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06627205 is a NA study of Autism and Autism Spectrum Disorder (ASD) that is actively recruiting participants, run by Stanford University. The registered enrollment target is 25 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06627205, a NA study of Autism and Autism Spectrum Disorder (ASD), is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The purpose of this open label trial is to examine the acceptability, tolerability, and feasibility and preliminary effectiveness of sleep restriction therapy for sleep problems in children with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist of parent-training in delivering the intervention.

Interventions

  • BEHAVIORAL Sleep Restriction Therapy

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2025-02-11
Est. Completion 2027-12
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT06627205

The ClinicalTrials.gov registry entry for NCT06627205 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (86% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Sleep Restriction Therapy is the first listed.

NCT06627205 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06627205 about?

NCT06627205 is a clinical study titled "Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism". The purpose of this open label trial is to examine the acceptability, tolerability, and feasibility and preliminary effectiveness of sleep restriction therapy for sleep problems in children with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist ...

What is the current status of trial NCT06627205?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-02-11. Estimated completion is 2027-12.

What conditions does trial NCT06627205 study?

This clinical trial studies the following conditions: Autism, Autism Spectrum Disorder (ASD).

What interventions are being tested in trial NCT06627205?

The interventions under investigation include: Sleep Restriction Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06627205?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06627205 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.